National Health Security (National Notifiable Disease List) Amendment Instrument 2022

Administered by Department of Health, Disability and Ageing

Legislation au F2022L00734 Not in force Legislative Instrument

Legislation content

EXPLANATORY STATEMENT

 

National Health Security Act 2007

 

National Health Security (National Notifiable Disease List) Amendment Instrument 2022

Authority

The National Health Security Act 2007 (the Act) provides for a national system of public health surveillance.

 

Subsection 11(1) of the Act provides that the Minister must, by legislative instrument, establish a list of diseases, to be called the National Notifiable Disease List (NNDL). 

 

Subsection 12(1) provides that if a disease outbreak is considered a public health risk, the Commonwealth Chief Medical Officer (CMO) may make temporary additions to the list, effective for a period of six months.  

Purpose

The purpose of the National Health Security (National Notifiable Disease List) Amendment Instrument 2022 (the Amending Instrument) is to amend the National Health Security (National Notifiable Disease List) Instrument 2018 to temporarily add ‘Monkeypox virus infection’ to the NNDL.

 

Background

Monkeypox is a viral zoonotic disease endemic in Central and West Africa and  occasionally exported to other regions. The monkeypox virus is typically transmitted to people from infected animals such as rodents and primates with secondary, human-to-human transmission relatively limited. 

In May 2022, cases of monkeypox were reported in several non-endemic regions, including Europe and North America with no reported travel links to endemic countries, indicating local transmission. Australia first reported cases in travellers returning from these regions on 20 May 2022.

Monkeypox is usually a self-limited disease, but complications such as bronchopneumonia, encephalitis, secondary bacterial infection, and blindness from corneal scarring can occur.

The introduction of monkeypox into Australia, the potential for human-to-human transmission and severe illness in vulnerable populations, poses a significant public health risk to Australia. 

There is an urgent need to understand the epidemiology and pathogenesis of monkeypox virus infection to inform public health response and control measures. Adding the disease to the NNDL enables the sharing of information about cases of the disease between States and Territories and the Commonwealth, the World Health Organization and relevant member states. Where information that is shared includes personal information, the Act provides for the use, disclosure and recording of the personal information to be restricted. Notification of cases to public health authorities will ensure that information is passed on quickly so that response measures can be put in place rapidly.       

Consultation

 

The Commonwealth Chief Medical Officer is not required to consult with State and Territory Health Ministers for temporary additions to the NNDL. The proposed addition has however, been endorsed by the Communicable Diseases Network Australia, the communicable disease expert committee of the Australian Health Protection Principal Committee.  

This Amending Instrument commences the day after it is registered.

This Amending Instrument is a legislative instrument for the purposes of the Legislation Act 2003.


ATTACHMENT

 

Details of the Instrument

 1    Name of Instrument

This section states that the Amending Instrument is the National Health Security (National Notifiable Disease List) Amendment Instrument 2022.

 2    Commencement

This section provides for the Amending Instrument to commence the day after it is registered.

 3    Authority

This section provides that subsection 12(1) of the National Health Security Act 2007 provides authority for the making of this Instrument.

 4   Schedule

This section provides for the amendment of the Instrument listed in Schedule 1.

SCHEDULE 1 – AMENDMENTS

National Health Security (National Notifiable Disease List) Instrument 2018

Item 1

Item 1 inserts a new item 38A ‘Monkeypox virus infection’ after item 38 in the table to subsection 6(1).

 

Item 2

Item 2 omits “Note” from the note at the end of section 6 and substitutes it with “Note 1”. This is because the note is renumbered as Note 1, as an additional note is added by the Amending Instrument.

 

Item 3

Item 3 adds Note 2 after Note 1 in section 6, to explain the operation of subsection 12(4) of the Act, which effects the temporary addition of ‘Monkeypox virus infection’ to the National Notifiable Disease List (NNDL). The note states that at the end of the period of 6 months after the Amending Instrument varies the NNDL, ‘Monkeypox virus infection’ will cease to be listed. The Minister can make a determination that the variation continues to have effect after the end of the period of 6 months after the list is varied, if certain requirements are met under subsection 12(6) of the Act.

Statement of Compatibility with Human Rights

Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011

 

National Health Security (National Notifiable Disease List) Amendment Instrument 2022

 

The National Health Security (National Notifiable Disease List) Amendment Instrument 2022 (the Amending Instrument) is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

 

Overview of the Amending Instrument

The Amending Instrument amends the National Health Security (National Notifiable Disease List) Instrument 2018 (the Principal Instrument) to improve the national surveillance of ‘Monkeypox virus infection’.

The amendment adds ‘Monkeypox virus infection’ to the Principal Instrument, making this disease nationally notifiable. This will make a clear statement of intent about the public health priority of the disease.

 

These amendments do not make any substantive changes to the law.

 

Human rights implications

The Amending Instrument engages the following human rights:

  • the right to privacy contained in Article 17 of the International Covenant on Civil and Political Rights, related to protection from arbitrary or unlawful interference with privacy; and
  • the right to the enjoyment of the highest attainable standard of physical and mental health under Article 12 of the International Covenant on Economic, Social and Cultural Rights.

The Amending Instrument is consistent with the right to privacy, as the Act provides that personal information regarding cases of ‘Monkeypox virus infection’ is protected information, with an associated offence provision for unauthorised use or disclosure. The Act permits the lawful sharing of personal information to support public health surveillance. The Act ensures that the impact on individual privacy is not arbitrary and is proportionate to the protection of public health.

The Amending Instrument promotes the right to health as it assists to protect public health in Australia by assisting with the exchange of information, including personal information in accordance with the provisions in the Act, to support public health surveillance. The Amending instrument also supports the rapid investigation and control of communicable disease outbreaks and other matters relating to public health.

 

Conclusion

The Amending Instrument is compatible with human rights because it promotes the right to the enjoyment of the highest attainable standard of physical and mental health and is consistent with the right to privacy.

 

Dr Sonya Bennett

 

Acting Commonwealth Chief Medical Officer

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.